LIPID DISORDERS IN NIDDM - IMPLICATIONS FOR TREATMENT

Diabetes conveys high risk lipid status for cardiovascular disease (CV D). To target the management of diabetic dyslipidaemia requests the un derstanding of metabolic basis of diabetic dyslipidaemia and its compo nents. Recent progress has opened new information to direct future lip id lowering intervention trials in type 2 diabetic patients. To reduce substantially the risk for CVD aggressive modification of all known r isk factors is warranted on the basis of existing data.